Immunogenicity 10862
Sample ID
3678
Response
Negative
Tumor Type
Melanoma
Gene Symbol
GPRC5A
Transcript ID
None
HLA INFO
B*44:02
TCR INFO
No TCR info found!
Full length protein sequence (357 aa)
MATTV
1
PDGCR
6
NGLKS
11
KYYRL
16
CDKAE
21
AWGIV
26
LETVA
31
TAGVV
36
TSVAF
41
MLTLP
46
ILVCK
51
VQDSN
56
RRKML
61
PTQFL
66
FLLGV
71
LGIFG
76
LTFAF
81
IIGLD
86
GSTGP
91
TRFFL
96
FGILF
101
SICFS
106
CLLAH
111
AVSLT
116
KLVRG
121
RKPLS
126
LLVIL
131
GLAVG
136
FSLVQ
141
DVIAI
146
EYIVL
151
TMNRT
156
NVNVF
161
SELSA
166
PRRNE
171
DFVLL
176
LTYVL
181
FLMAL
186
TFLMS
191
SFTFC
196
GSFTG
201
WKRHG
206
AHIYL
211
TMLLS
216
IAIWV
221
AWITL
226
LMLPD
231
FDRRW
236
DDTIL
241
SSALA
246
ANGWV
251
FLLAY
256
VSPEF
261
WLLTK
266
QRNPM
271
DYPVE
276
DAFCK
281
PQLVK
286
KSYGV
291
ENRAY
296
SQEEI
301
TQGFE
306
ETGDT
311
LYAPY
316
STHFQ
321
LQNQP
326
PQKEF
331
SIPRA
336
HAWPS
341
PYKDY
346
EVKKE
351
GS
356
Mutation Information
DNA mutation:
None
Peptide Range:
26 ~ 50
Mut AA position:
38 (13 in Wild Type peptide)
Alignment
Wild Type:
"AWGIVLETVATAGVVTSVAFMLTLP
||||||||||||.||||||||||||
Mutant:
AWGIVLETVATAEVVTSVAFMLTLP"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) GPRC5A
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
ELISPOT assay